Cargando…

Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients

BACKGROUND: Interferon-based therapy (IBT) has been the standard of care for hepatitis C virus (HCV) infection. However, conflicting results exist regarding the effects of IBT on risk of developing hepatocellular carcinoma (HCC) and cirrhosis-associated complications, and most included highly select...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Ching-Sheng, Huang, Chun-Jen, Kao, Jia-Horng, Lin, Hans Hsienhong, Chao, You-Chen, Fan, Yen-Chun, Tsai, Pei-Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720923/ https://www.ncbi.nlm.nih.gov/pubmed/23894660 http://dx.doi.org/10.1371/journal.pone.0070458

Ejemplares similares

Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma
por: Hsu, Ching-Sheng, et al.
Publicado: (2015)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Association of Rheumatoid Arthritis and Hepatitis B Infection: A Nationwide Nested Case-Control Study From 1999 to 2009 in Taiwan
por: Hsu, Ching-Sheng, et al.
Publicado: (2016)

Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy
por: Hsu, Ching-Sheng, et al.
Publicado: (2016)

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
por: Liu, Chen-Hua, et al.
Publicado: (2021)

Differences in complications between hepatitis B-related cirrhosis and alcohol-related cirrhosis
por: Zhuang, Yu-Pei, et al.
Publicado: (2021)

Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan
por: Hung, Tsung-Hsing, et al.
Publicado: (2017)

Hyponatremia in Hepatocellular Carcinoma Complicating with Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis
por: Lee, Chern-Horng, et al.
Publicado: (2023)

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2014)

Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses
por: Yeh, Ming-Lun, et al.
Publicado: (2011)

A Novel Pathological Scoring System for Hepatic Cirrhosis with Hepatocellular Carcinoma
por: Dong, Wei, et al.
Publicado: (2020)

Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis
por: Huang, Yi-Wen, et al.
Publicado: (2022)

Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients
por: Wu, Hui-Lin, et al.
Publicado: (2016)

Tumor Necrosis Factor-Alpha Induced by Hepatitis B Virus Core Mediating the Immune Response for Hepatitis B Viral Clearance in Mice Model
por: Tzeng, Horng-Tay, et al.
Publicado: (2014)

Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
por: Liu, Chen-Hua, et al.
Publicado: (2018)

Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
por: Hsu, Yao-Chun, et al.
Publicado: (2023)

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
por: Shen, Jiliang, et al.
Publicado: (2017)

Interferon gamma polymorphisms and hepatitis B virus-related liver cirrhosis risk in a Chinese population
por: Sun, Yifan, et al.
Publicado: (2015)

Incidence of Type 2 Diabetes in Patients With Chronic Hepatitis C Receiving Interferon-Based Therapy
por: Tsai, Ming-Chieh, et al.
Publicado: (2020)

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016)

Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
por: Hsu, Wei-Fan, et al.
Publicado: (2020)

Differentiation between alcohol-associated cirrhosis and hepatitis B-associated cirrhosis based on hepatic complications and psychological symptoms
por: Liang, Yun-Fang, et al.
Publicado: (2023)

Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus–Related Cirrhosis
por: Tsai, Ming-Chao, et al.
Publicado: (2022)

Decreasing Postoperative Pulmonary Complication Following Laparoscopic Surgery in Elderly Individuals with Colorectal Cancer: A Competing Risk Analysis in a Propensity Score–Weighted Cohort Study
por: Chern, Yih-Jong, et al.
Publicado: (2021)

Endoscopic discectomy of L5-S1 disc herniation via an interlaminar approach: Prospective controlled study under local and general anesthesia
por: Chen, Hsien-Te, et al.
Publicado: (2011)

Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
por: Lin, Chih-Lin, et al.
Publicado: (2023)

Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis
por: Wu, Hsin-Yun, et al.
Publicado: (2023)

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
por: Lee, Mei-Hsuan, et al.
Publicado: (2017)

Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis
por: Kilany, Shimaa, et al.
Publicado: (2021)

Effects of acute critical illnesses on the performance of interferon-gamma release assay
por: Huang, Chun-Ta, et al.
Publicado: (2016)

Hepatocellular carcinoma in hemodialysis patients
por: Lee, Chern-Horng, et al.
Publicado: (2017)

Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2023)

Clinical Implication of Performance Status in Patients with Hepatocellular Carcinoma Complicating with Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

Achieving sustained virologic response after interferon‐free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis
por: Meissner, E. G., et al.
Publicado: (2016)

Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study
por: Liao, Yen-Hsiang, et al.
Publicado: (2020)

Increased risk of bladder cancer in young adult men with hyperlipidemia: A population-based cohort study
por: Shih, Hung-Jen, et al.
Publicado: (2021)

Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan
por: Tsai, Fuu-Jen, et al.
Publicado: (2020)

Pathogenesis and management of alcoholic liver cirrhosis: a review
por: Huang, Yi-wen, et al.
Publicado: (2011)

Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis
por: Kuan, Yi-Chun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m3ij1n9stihuokduqbk8i9pa3o